Home ยป “Pfizer Researchers Identify Potent Oral SHP2 Inhibitors for Oncology Drug Discovery”

“Pfizer Researchers Identify Potent Oral SHP2 Inhibitors for Oncology Drug Discovery”

by satcit

https://pubmed.ncbi.nlm.nih.gov/38116446

Researchers from Pfizer discovered a new class of potent and orally bioavailable SHP2 inhibitors, 5-azaquinoxaline derivatives, as promising candidates for oncology drug discovery.

You may also like

Leave a Comment